Latest News

Aotearoa Clinical Trials Expands to New Site in Botany, East Auckland, Strengthening Community Access to Clinical Trials

10/02/2025

Aotearoa Clinical Trials is pleased to announce the opening of a new, third site in Botany, East Auckland, expanding its reach and further cementing its commitment to the local community. This new standalone site will allow the clinical trial organisation to provide enhanced access to a diverse range of participants, while strategically supporting the Counties Manukau region’s rapidly growing population.

#TALK Research - January Newsletter

30/01/2025

GIP and glucagon receptor agonists has the potential to change the medical world and the effects of obesity.

HRC Grant Awarded: REducing the PrOgression of diabetic kidney disease: a cluster Randomised Trial

22/01/2025

We’re excited to announce that Dr. Viliami Tutone and Dr. Kalpa Jayanatha from Counties Manukau Health have received a $1.4 million Health Delivery Project Grant from the Health Research Council of New Zealand! This grant will support an innovative project aimed at tackling diabetic kidney disease (DKD) in Auckland, proudly hosted by Aotearoa Clinical Trials.

Annual Report FY24

18/11/2024

#TALK Research - August Newsletter

09/08/2024

Middlemore Hospital has a strong research culture and a proud history of engagement and success in research across many therapeutic areas and research types.

HRC project grant awarded for ROADMAP – a RandOmised Arthroplasty infection worlDwide Multidomain Adaptive Platform trial

07/08/2024

Researchers looking to improve management strategies for prosthetic joint infections were recently awarded a $1.4 million project grant from the Health Research Council (HRC).

Aotearoa Clinical Trials Partners with Care Access to Expand Availability of Clinical Trials in Diverse and Under-Represented Communities Throughout New Zealand

24/07/2024

U.S.-based Care Access to leverage its renowned decentralised capabilities to expand research availability to more communities in New Zealand

#TALK Research - April Newsletter

24/04/2024

GIP and glucagon receptor agonists has the potential to change the medical world and the effects of obesity.

Aotearoa Clinical Trials Partner as a site with Pacific Primary Care Provider South Seas Healthcare

29/02/2024

Aotearoa Clinical Trials Becomes First Site in New Zealand to Achieve both GCSA Certification and Workforce Quality Accreditation

22/02/2024

Aotearoa Clinical Trials is working to the highest global best-practice standards.

#TALK Research - November Newsletter

05/12/2023

GIP and glucagon receptor agonists has the potential to change the medical world and the effects of obesity.

Maternal RSV Vaccine Approved by FDA

27/10/2023

Aotearoa Clinical Trials is proud to have been part of the MATISSE Trial. ABRYSVO™, Pfizer’s bivalent RSV preF vaccine for the prevention of Lower Respiratory Tract Disease (LRTD) and severe LRTD caused by RSV in infants from birth up to six months of age was approved by the FDA on 21st August 2023.